A mosaic approach for understanding stimulant and opioid use and use disorder trajectories and associated consequences in US adults

Active Definitive Contract Awarded Last action

Contract number
75F40124C00131
Awardee
Awarding agency
Obligated
$1,649,006

Award facts

Contract value 74% obligated
  • $1,649,006.00 Current, with exercised options
  • $2,235,290.00 Potential, with all options
Completion date 53% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Ann Arbor, MI 48109, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 $547,658
Other Administrative Action P00003 $0
Exercise an Option P00002 $531,568
Other Administrative Action P00001 · The purpose of this modification is to change the contracting officer's representative (COR) from mary johnson to tara argual. $0
Original award $569,780

About this award

Written by GovTribe AI ·

The Food and Drug Administration awarded a $2.235 million definitive contract to Regents Of The University Of Michigan for a mosaic approach to understanding stimulant and opioid use and use disorder trajectories and associated consequences in US adults on September 12, 2024, under firm fixed-price terms with no set-aside.

Place of performance is Ann Arbor, Michigan. The contract runs through September 29, 2028. The originating solicitation calls for a multi-dataset research effort examining stimulant and opioid use trajectories and their consequences, with coordination of analyses across three major datasets, maintenance of common measures, coding, and data analysis activities.

University of Illinois at Chicago, under the Board of Trustees of the University of Illinois, supports the effort by coordinating analyses across datasets and performing data analysis work (award date April 29, 2026). Texas State University provides MTF-based reporting and manuscript support including FDA staff collaboration on publications and national scientific meeting presentations (award date February 19, 2025). The General Hospital Corporation, operating as Massachusetts General Hospital's Research Management Division, contributes longitudinal data from an NIH HEAL initiative grant and ongoing MGH research (award date February 19, 2025).

Service Contract Inventory reporting for FY2025 reflects $510 thousand invoiced across 2.1 FTEs with no subcontractor hours—the prime self-performed all reported labor.

Subawards

Subcontractor Amount Awarded
University Of Illinois A MOSAIC APPROACH FOR UNDERSTANDING STIMULANT AND OPIOID USE AND USE DISORDER TRAJECTORIES AND ASSOCIATED CONSEQUENCES IN US ADULTS Dr. Pasman will help… $27,856
Texas State University A MOSAIC APPROACH FOR UNDERSTANDING STIMULANT AND OPIOID USE AND USE DISORDER TRAJECTORIES AND ASSOCIATED CONSEQUENCES IN US ADULTS He will assist with… $206,294
The General Hospital Corporation A MOSAIC APPROACH FOR UNDERSTANDING STIMULANT AND OPIOID USE AND USE DISORDER TRAJECTORIES AND ASSOCIATED CONSEQUENCES IN US ADULTS As part of the proposed… $231,024

Quick answers

Who was awarded contract 75F40124C00131?

75F40124C00131 was awarded to Regents Of The University Of Michigan by Food and Drug Administration (Department of Health and Human Services) on September 12, 2024.

How much is contract 75F40124C00131 worth?

The government has obligated $1,649,006 on 75F40124C00131. Its potential value, with all options, is $2,235,290.

Was contract 75F40124C00131 competed?

The extent of competition for 75F40124C00131 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login